Page last updated: 2024-12-11

vitamin a2

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

vitamin A2: RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

all-trans-3,4-didehydroretinol : A retinoid derived from 3,4-desaturation of the beta-ionone ring of all-trans-retinol. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6436043
CHEMBL ID1797132
CHEBI ID132246
SCHEMBL ID15904
MeSH IDM0082582

Synonyms (30)

Synonym
LMPR01090008
3,4-didehydro-retinol
all-trans-3,4-didehydro retinol
vitamin a2
79-80-1
3,4-didehydroretinol
3-dehydroretinol
CHEBI:132246
all-trans-3-dehydroretinol
3,4-didehydro-all-trans-retinol
dehydroretinol
all-trans-3,4-didehydroretinol
3-dehydoretinol
(2e,4e,6e,8e)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexa-1,3-dien-1-yl)nona-2,4,6,8-tetraen-1-ol
CHEMBL1797132
unii-104621892x
einecs 201-226-4
104621892x ,
3-dehydroretinol [who-dd]
3-dehydroretinol [mi]
retinol2
dehydroretinol. 3-
3-dehydro retinol
(all-e)-3,7-dimethyl-9-(2,6,6-trimethyl-1,3-cyclohexadien-1-yl)-2,4,6,8-nonatetraen-1-ol
SCHEMBL15904
C21797
va2
Q24390934
DTXSID401018959
3,4-dehydroretinol;all-trans- 3-dehydroretinol

Research Excerpts

Effects

ExcerptReferenceRelevance
"Vitamin A2 has for the first time been identified in a human tissue and, in contrast to vitamin A1, its concentration in the epidermis is markedly increased in a hyperkeratotic condition (Psoriasis vulgaris)."( The identification of dehydroretinol (vitamin A2) in human skin.
Vahlquist, A, 1980
)
1.97

Bioavailability

ExcerptReferenceRelevance
" The noncompetable, noninhibitable component of all-trans-retinol absorption corresponded to the total absorption rate for 13-cis- and 9-cis-retinol and retinal."( Specificity of the retinol transporter of the rat small intestine brush border.
Dew, SE; Ong, DE, 1994
)
0.29

Dosage Studied

ExcerptRelevanceReference
"5 h might provide information analogous to that obtained from two blood samples in the conventional relative dose-response method."( A modified relative dose-response assay employing 3,4-didehydroretinol (vitamin A2) in rats.
Olson, JA; Tanumihardjo, SA, 1988
)
0.51
" Four cis isomers (9-cis-, 11-cis-, 13-cis- and 9,13-di-cis-retinol or corresponding dehydroretinols ) were found to occur naturally together with the main all-trans form, confirming the need to separate geometric isomers in every dosage of vitamin A-containing compounds."( High-performance liquid chromatography of the unsaponifiable from samples of marine and freshwater fish: fractionation and identification of retinol (vitamin A1) and dehydroretinol (vitamin A2) isomers.
Stancher, B; Zonta, F, 1984
)
0.46
" The acceptable time between administering the oral dose and obtaining a blood sample was validated as being 4-7 h in a group of children (n = 84) by taking two blood samples per child between 3 and 7 h after dosing with DRA."( Refinement of the modified-relative-dose-response test as a method for assessing vitamin A status in a field setting: experience with Indonesian children.
Cheng, JC; Karyadi, D; Olson, JA; Permaesih, D; Rustan, E; Tanumihardjo, SA, 1996
)
0.29
" The modified-relative-dose-response (MRDR) method suffers from a relatively large intraindividual variation in the ratio of dehydroretinol to retinol because of vulnerability of the dehydroretinol concentration to laboratory errors and to variation in dosing and absorption."( Evaluation of biochemical indicators of vitamin A status in breast-feeding and non-breast-feeding Indonesian women.
de Pee, S; West, CE; Yuniar, Y, 1997
)
0.3
" The MRDR method yielded large intra-individual variation in the ratio of dehydroretinol to retinol because of vulnerability to laboratory errors and variation in dosing and absorption."( Evaluation of biochemical indicators of vitamin A status in breast-feeding and non-breast-feeding Indonesian women.
de Pee, S; West, CE; Yuniar, Y, 1997
)
0.3
"The modified-relative-dose-response (MRDR) test, which requires a blood sample after dosing with 3,4-didehydroretinyl acetate (DRA), has been used to determine vitamin A (VA) status of individuals and groups worldwide."( The modified-relative-dose-response values in serum and milk are positively correlated over time in lactating sows with adequate vitamin A status.
Li, J; Surles, RL; Tanumihardjo, SA, 2006
)
0.33
"5 d) from these sows were weaned onto a VA-free diet for 1 wk, assigned to 4 groups, and dosed orally with 0, 26."( Vitamin A concentrations in piglet extrahepatic tissues respond differently ten days after vitamin A treatment.
Sun, T; Surles, RL; Tanumihardjo, SA, 2008
)
0.35
" Weanling rats (n 40) were fed a vitamin A-deficient diet for 8 weeks, divided into four treatment groups (n 10/group) and orally dosed with 50 nmol/d retinyl acetate (14."( α-Retinol and 3,4-didehydroretinol support growth in rats when fed at equimolar amounts and α-retinol is not toxic after repeated administration of large doses.
Dever, JT; Riabroy, N; Tanumihardjo, SA, 2014
)
0.4
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
human xenobiotic metaboliteAny human metabolite produced by metabolism of a xenobiotic compound in humans.
marine xenobiotic metaboliteAny metabolite produced by metabolism of a xenobiotic compound in marine macro- and microorganisms.
mouse metaboliteAny mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
retinoidOxygenated derivatives of 3,7-dimethyl-1-(2,6,6-trimethylcyclohex-1-enyl)nona-1,3,5,7-tetraene and derivatives thereof.
vitamin AAny member of a group of fat-soluble retinoids produced via metabolism of provitamin A carotenoids that exhibit biological activity against vitamin A deficiency. Vitamin A is involved in immune function, vision, reproduction, and cellular communication.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID603957Octanol-water partition coefficient, log P of the compound2008European journal of medicinal chemistry, Apr, Volume: 43, Issue:4
QSPR modeling of octanol/water partition coefficient for vitamins by optimal descriptors calculated with SMILES.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (109)

TimeframeStudies, This Drug (%)All Drugs %
pre-199053 (48.62)18.7374
1990's28 (25.69)18.2507
2000's16 (14.68)29.6817
2010's8 (7.34)24.3611
2020's4 (3.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 31.81

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index31.81 (24.57)
Research Supply Index4.73 (2.92)
Research Growth Index4.39 (4.65)
Search Engine Demand Index66.86 (26.88)
Search Engine Supply Index3.24 (0.95)

This Compound (31.81)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (1.82%)5.53%
Reviews1 (0.91%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other107 (97.27%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]